Formation of FIQH Parameters for Treatment Using Platelet-Rich Plasma (PRP)

Authors

  • Mohd Hapiz Mahaiyadin
  • Hisyam Mohd Radzi
  • Roshaimizam Suhaimi
  • Tuan Hulwani Tuan Mohammad
  • Arieff Salleh Rosman
  • Aqeel Khan

DOI:

https://doi.org/10.47059/revistageintec.v11i4.2193

Abstract

The platelet-rich plasma (PRP) treatment is a method of medical treatment using sources from processed human blood. The process is intended to isolate PRP from human blood. It is a component of blood plasma that is enriched with platelets. Platelets are small blood cells that contain more than 30 bioactive proteins that play an important role in the process of blood clotting and tissue healing. Since the PRP method is a treatment that uses sources of human blood for the purpose of treatment whether aesthetic or therapeutic treatment, it certainly requires a thorough study of fiqh for its use. Islamic law advises its followers to strive to treat any illness or reduce the pain experienced by a person. However, every treatment used including PRP treatment, is still subject to the control of the principles of Islamic law to ensure that the treatment is not contradicting with Islamic law. Thus, this study was conducted using a qualitative method based on the method of library research and interviews to produce a fiqh parameter for PRP-based treatment. The results of the study concluded that three principles in the formation of these parameters need to be examined, namely; (i) parameters for determining the validity of masyaqqah, (ii) parameters for adverse effects of the disease on patients and (iii) parameters for determining the types of items that are prohibited (muharramat). Therefore, treatment using the PRP whether treatment for aesthetic or therapeutic purposes must comply with the details in all the relevant parameters as the method of treatment cannot be permitted totally. In addition, PRP treatment should also be recommended by a qualified medical practitioner and implemented according to proper procedures to avoid the risk of side effects towards patients

Downloads

Published

2021-07-11

Issue

Section

Articles